Skip to main content
Toggle navigation
Login
Search
Home
Program Book
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Email
Tweet
Alexis Batjiaka, PharmD (she/her/hers)
PGY2 Hematology/Oncology Pharmacy Resident
Hospital of the University of Pennsylvania
Poster(s):
(024) Characterization of Combination Ruxolitinib and Tyrosine Kinase Inhibitors in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Friday, April 5, 2024
12:00 PM – 2:00 PM
ET
Email Alexis